leon-nanodrugs

📍 München, Germany🗓 Founded 2011👥 14 employees💰 Last funded Jan 2020
Pharmaceutical Manufacturing🌐 leon-nanodrugs.com
Website LinkedIn
Leading Technology for the Encapsulation of nucleic acids, biomolecules, and other APIs. Our technology solves your current encapsulation challenges. We offer highly flexible GMP manufacturing solutions for your genetic payloads and other molecules, making manufacturing of transfection material a highly flexible and commercially viable proposition. LEON utilises its’ proprietary nano technology platform for the continuous manufacturing of SMART nanoparticles (ranging from surface stablilised polymeric through to lipid nanoparticles (LNPs) and liposomes). The Company is working with world class industry partners for both process and product development.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Switzerland
1
Germany
1
Frequently asked questions
Who invested in leon-nanodrugs?
leon-nanodrugs has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did leon-nanodrugs last raise funding?
The most recent investment in leon-nanodrugs recorded on gritt.io was in January 2020.
When was leon-nanodrugs founded?
leon-nanodrugs was founded in 2011.
What industry is leon-nanodrugs in?
leon-nanodrugs operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is leon-nanodrugs based?
leon-nanodrugs is headquartered in München, Germany.